Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is the fastest-growing liver disease in the world. Despite targeted agents which are needed to provide permanent benefits for patients with NAFLD, no drugs have been approved to treat NASH. Thyroid hormone is an important signaling molecule to maintain norma...
Main Authors: | Man Zhao, Huazhong Xie, Hao Shan, Zhihua Zheng, Guofeng Li, Min Li, Liang Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/3/1102 |
Similar Items
-
Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196
by: Georg Sebastian Hönes, et al.
Published: (2022-11-01) -
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis
by: Andrea Caddeo, et al.
Published: (2023-02-01) -
Thyroid Hormone Receptor Isoforms Alpha and Beta Play Convergent Roles in Muscle Physiology and Metabolic Regulation
by: Annarita Nappi, et al.
Published: (2022-04-01) -
Thyroid Hormones and Functional Ovarian Reserve: Systemic vs. Peripheral Dysfunctions
by: Marco Colella, et al.
Published: (2020-06-01) -
Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges
by: Vito Antonio Baldassarro, et al.
Published: (2023-08-01)